Tearlab Corp Receivables Turnover Ratio (TEAR), from the first quarter 2020 to the first quarter 2019 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tearlab Corp  (TEAR)
 

Tearlab Accounts Receivables Turnover Ratio from the first quarter 2020 to the first quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Tearlab Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2020 to a ratio of 22.47, this represents a new company high. This is a clear indication for improving liquidity at Tearlab Corp's clients. Average receivable collection period, for the Tearlab in Mar 31 2020 quarter, has decreased to 16 days, compared to 17 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 49 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2020 from 476 to 649.

What is Receivable Turnover Ratio?
What is Tearlab Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TEAR Receivables Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Receivable Change -14.75 % -22.68 % -25.85 % -11.71 % -24.38 %
Y / Y Revenue Change -7.94 % -5.71 % -8.52 % -8.76 % -14.21 %
Receivable Turnover Ratio (TTM) 22.47 22.02 20.98 19.91 19.76
TEAR's Total Ranking # 649 # 476 # 515 # 526 # 528
Accounts Receivable average collection period days 16 17 17 18 18
Seq. Receivable Change 2.07 % -6.24 % -12.91 % 2.28 % -7.42 %
Seq. Revenue Change -9.83 % 0.32 % -3.81 % 5.8 % -7.65 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 50
Overall Market # 649

Receivable Turnover Ratio Statistics
High Average Low
22.47 11.6 4.99
(Mar 31 2020)   (Dec 31 2013)





TEAR Company Profile • Back to TEAR Efficiency Comparisons • Compare TEAR Receivables Turnover Ratio to its Competitors

Financial Statements
Tearlab's Accounts Receivable $ 1 Millions Visit TEAR's Balance sheet
Tearlab's Sales TTM $ 22 Millions Visit TEAR's Income Statement
Sources of TEAR's Revenues Visit TEAR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TEAR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TEAR's Growth Rates TEAR's Roa TEAR's Inventory Turnover Ratio TEAR's Dividend Comparisons
TEAR's Profitability Ratios TEAR's Roi TEAR's Asset Turnover Ratio TEAR's Dividend Growth
TEAR's Valuation Ratios TEAR's Roe TEAR's Financial Strength Ratios TEAR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2020 Receivable at quarter ending Mar 31 2020
Zeo Scientifix Inc   64.82 $ 2.470  Millions$ 0.038  Millions
Telesis Bio Inc   63.40 $ 10.984  Millions$ 0.173  Millions
U s Stem Cell Inc   62.71 $ 1.821  Millions$ 0.029  Millions
Nature s Sunshine Products inc   49.90 $ 366.869  Millions$ 7.352  Millions
Sonida Senior Living Inc   49.28 $ 439.053  Millions$ 8.909  Millions
Healthlynked Corp  48.73 $ 4.891  Millions$ 0.100  Millions
Nanomix Corp  47.74 $ 0.015  Millions$ 0.000  Millions
Health right Discoveries Inc   47.21 $ 2.806  Millions$ 0.059  Millions
Immunogen inc   45.49 $ 86.974  Millions$ 1.912  Millions
Crispr Therapeutics Ag  45.26 $ 289.419  Millions$ 6.394  Millions
U S Physical Therapy Inc  44.86 $ 478.455  Millions$ 10.665  Millions
Scorpius Holdings inc   44.25 $ 3.250  Millions$ 0.073  Millions
National Vision Holdings Inc   38.47 $ 1,732.820  Millions$ 45.041  Millions
Editas Medicine Inc   37.60 $ 24.185  Millions$ 0.643  Millions
Chinook Therapeutics Inc   36.60 $ 27.270  Millions$ 0.745  Millions
Blueprint Medicines Corporation  35.91 $ 74.853  Millions$ 2.084  Millions
Endonovo Therapeutics Inc   29.42 $ 0.335  Millions$ 0.011  Millions
Brookdale Senior Living Inc   29.09 $ 3,982.621  Millions$ 136.927  Millions
Cardiff Lexington Corporation  25.77 $ 4.734  Millions$ 0.184  Millions
Bellicum Pharmaceuticals Inc   25.09 $ 7.615  Millions$ 0.304  Millions
Igc Pharma Inc   25.06 $ 4.072  Millions$ 0.163  Millions
Regeneron Pharmaceuticals Inc   24.86 $ 7,979.800  Millions$ 321.000  Millions
Bicycle Therapeutics Plc  24.26 $ 8.546  Millions$ 0.352  Millions
Cogent Biosciences Inc   24.22 $ 26.477  Millions$ 1.093  Millions
Syneos Health Inc   23.97 $ 4,720.164  Millions$ 196.913  Millions
Mymetics Corporation  23.82 $ 1.030  Millions$ 0.043  Millions
Advanced Container Technologies Inc   22.87 $ 2.100  Millions$ 0.092  Millions
Delcath Systems Inc   22.75 $ 1.604  Millions$ 0.071  Millions
Ernexa Therapeutics Inc   22.50 $ 17.368  Millions$ 0.772  Millions
Tearlab Corp  22.47 $ 22.216  Millions$ 0.989  Millions

Date modified: 2026-10-07T00:41:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.